{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T17:57:33Z","timestamp":1720547853933},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3507,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/sj.ki.5000403","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T01:54:49Z","timestamp":1318643689000},"page":"S9-S12","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S101","title":["Overcoming barriers that inhibit proper treatment of anemia"],"prefix":"10.1016","volume":"69","author":[{"given":"R.","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5000403_bb0010","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V1092029","article-title":"An indistinct balance: the safety and efficacy of parenteral iron therapy","volume":"10","author":"Besarab","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000403_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/ajkd.2002.33917","article-title":"Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury","volume":"40","author":"Zager","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000403_bb0020","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69035.x","article-title":"Iron overload in renal failure patients: changes since the introduction of erythropoietin therapy","volume":"55","author":"Eschbach","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000403_bb0025","first-page":"35","article-title":"Function and regulation of transferrin and ferritin","volume":"35","author":"Ponka","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1038\/sj.ki.5000403_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM196703232761202","article-title":"Erythropoiesis in patients with renal failure undergoing chronic dialysis","volume":"276","author":"Eschbach","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000403_bb0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(80)92047-4","article-title":"Iron-overload-associated myopathy in patients on maintenance haemodialysis: a histocompatibility-linked disorder","volume":"2","author":"Bregman","year":"1980","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5000403_bb0040","first-page":"S182","article-title":"K\/DOQI clinical practice guidelines for anemia of chronic kidney disease","volume":"37","author":"National Kidney Foundation","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5000403_bb0045","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0030","article-title":"Iron and infection: clinical experience","volume":"34","author":"Hoen","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000403_bb0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1755.2003.00125.x","article-title":"High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity","volume":"64","author":"Deicher","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000403_bb0055","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/ndt\/15.11.1827","article-title":"Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration","volume":"15","author":"Parkkinen","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000403_bb0060","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","article-title":"Administration of parenteral iron and mortality among hemodialysis patients","volume":"15","author":"Feldman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000403_bb0065","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/j.1523-1755.2004.00742.x","article-title":"Parenteral iron therapy exacerbates experimental sepsis. Rapid communication","volume":"65","author":"Zager","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000403_bb0070","doi-asserted-by":"crossref","first-page":"F290","DOI":"10.1152\/ajprenal.00342.2004","article-title":"Parenteral iron compounds sensitize mice to injury-initiated TNF-\u03b1 mRNA production and TNF-\u03b1 release","volume":"288","author":"Zager","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5000403_bb0075","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1523-1755.2005.00565.x","article-title":"Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy","volume":"68","author":"Zager","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5000403_bb0080","first-page":"16","article-title":"Management of blood pressure changes during recombinant human erythropoietin therapy","volume":"9","author":"Levin","year":"1989","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5000403_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(88)90293-0","article-title":"Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy","volume":"1","author":"Raine","year":"1988","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5000403_bb0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2796.1992.tb01246.x","article-title":"Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin","volume":"231","author":"Linde","year":"1992","journal-title":"J Intern Med"},{"key":"10.1038\/sj.ki.5000403_bb0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000187571","article-title":"Erythropoietin increases blood pressure in normotensive and hypertensive rats","volume":"65","author":"Muntzel","year":"1993","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5000403_bb0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0272-6386(97)90198-0","article-title":"Endogenous erythropoietin correlates with blood pressure in essential hypertension","volume":"29","author":"Schmieder","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000403_bb0105","first-page":"193","article-title":"Changes in diurnal blood pressure variation and red cell and plasma volumes in patients with renal failure who develop erythropoietin-induced hypertension","volume":"44","author":"Jones","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5000403_bb0110","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1681\/ASN.V4111874","article-title":"Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy","volume":"4","author":"Kaupke","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000403_bb0115","first-page":"E113","article-title":"Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure","volume":"271","author":"Vaziri","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5000403_bb0120","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJM199010043231418","article-title":"Erythropoietin-associated hypertension","volume":"323","author":"Baskin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000403_bb0125","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1097\/01.ASN.0000145436.09176.A7","article-title":"Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials","volume":"15","author":"Strippoli","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000403_bb0130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ki.1995.354","article-title":"Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure","volume":"48","author":"Hand","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000403_bb0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"Am J Med"},{"key":"10.1038\/sj.ki.5000403_bb0140","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(04)01086-8","article-title":"Epoetin requirements predict mortality in hemodialysis patients","volume":"44","author":"Zhang","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000403_bb0145","doi-asserted-by":"crossref","first-page":"c30","DOI":"10.1159\/000088308","article-title":"Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects","volume":"102","author":"Annuk","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/sj.ki.5000403_bb0150","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815513963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815513963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:11:42Z","timestamp":1639170702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815513963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"alternative-id":["S0085253815513963"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5000403","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}